Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isoleucine-containing anti-inflammatory facial cream versus standard emollient in children with facial atopic dermatitis
NL-OMON21723Not yet recruiting
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Sep 2013
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of Isoleucine, nicotinamide and glycerol in atopic dermatitis (AD) (2 arms), sponsored by IRCCS San Matteo Foundation. Primary endpoint: EASI score. Planned start Sep 2013; status: not yet recruiting.
02
Drugs
Isoleucinenicotinamideglycerol
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NL-OMON21723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21723.